These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37305593)

  • 1. Community Pharmacist Provision of Non-Dispensing Services in Health Professional Shortage Areas.
    Kessinger H; Landis E; DiPietro Mager N; Kier K
    Innov Pharm; 2022; 13(4):. PubMed ID: 37305593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing community pharmacy services in health professional shortage areas across Wisconsin.
    Look KA; Black P; Arzt J; Crahan J; Helgeson CB; Lucey MS; Lee M; Rox KR; Portillo E
    J Am Pharm Assoc (2003); 2024; 64(2):506-511.e3. PubMed ID: 37940092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas.
    Murphy EM; West L; Jindal N
    J Am Pharm Assoc (2003); 2021; 61(6):651-660.e1. PubMed ID: 34531121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illustrating access to community pharmacies in Wisconsin.
    Look KA; Dekeyser C; Conjurske S; Platta M; Bohnen C; Black P; Portillo E
    J Am Pharm Assoc (2003); 2021; 61(4):492-499. PubMed ID: 33707122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of health professional shortage areas to health status. Implications for health manpower policy.
    Kohrs FP; Mainous AG
    Arch Fam Med; 1995 Aug; 4(8):681-5. PubMed ID: 7620597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ohio Community Pharmacist Provision of Clinical Preventive Services.
    Alexander S
    Innov Pharm; 2019; 10(1):. PubMed ID: 34007532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health professional shortage and health status and health care access.
    Liu JJ
    J Health Care Poor Underserved; 2007 Aug; 18(3):590-8. PubMed ID: 17675715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists.
    Bakhireva LN; Bautista A; Cano S; Shrestha S; Bachyrycz AM; Cruz TH
    Subst Abus; 2018; 39(3):331-341. PubMed ID: 29043922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Accessibility to Eye Care in the United States.
    Soares RR; Mokhashi N; Sharpe J; Zhang Q; Hinkle J; Patel SN; Ho AC; Yonekawa Y; Hsu J
    Ophthalmology; 2023 Apr; 130(4):354-360. PubMed ID: 36427602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Federally qualified health centers reduce the primary care provider gap in health professional shortage counties.
    Xue Y; Greener E; Kannan V; Smith JA; Brewer C; Spetz J
    Nurs Outlook; 2018; 66(3):263-272. PubMed ID: 29685322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' perceived barriers providing non-dispensing services to underserved populations.
    Blazejewski L; Vaidya V; Pinto S; Gaither C
    J Community Health; 2013 Oct; 38(5):812-22. PubMed ID: 23519581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct patient care services by community and ambulatory care pharmacists in Idaho.
    Nguyen E; Holmes JT; Narsinghani R; O'Connor S; Fuit MW; Thaden L; Robinson R
    Int J Clin Pharm; 2020 Dec; 42(6):1480-1489. PubMed ID: 32860182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives and perceived barriers to pharmacist-prescribed tobacco cessation services in the community pharmacy setting.
    Xiong S; Willis R; Lalama J; Farinha T; Hamper J
    J Am Pharm Assoc (2003); 2021; 61(4S):S39-S48. PubMed ID: 33483273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed changes to designations of medically underserved populations and health professional shortage areas: effects on rural areas.
    Goldsmith LJ; Ricketts TC
    J Rural Health; 1999; 15(1):44-54. PubMed ID: 10437330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliminating primary care health professional shortage areas: the impact of Title VII generalist physician education.
    Politzer RM; Hardwick KS; Cultice JM; Bazell C
    J Rural Health; 1999; 15(1):11-20. PubMed ID: 10437327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.